estriol has been researched along with Sexual Dysfunction, Physiological in 8 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Sexual Dysfunction, Physiological: Physiological disturbances in normal sexual performance in either the male or the female.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effect of a combination of vaginal ultra-low-dose estriol with lactobacilli on the sexual functioning domain of quality of life during the treatment of breast cancer survivors on an aromatase inhibitor with vaginal atrophy." | 7.81 | Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer. ( Bellen, G; Buchholz, S; Donders, G; Grob, P; Lintermans, A; Mögele, M; Neven, P; Ortmann, O; Prasauskas, V, 2015) |
| "Our study showed that vaginal supplementation with estriol 50 μg/g gel or with hyaluronic acid could reduce the de novo dyspareunia related to COC." | 5.20 | A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive. ( Bogani, G; Braghiroli, A; Cromi, A; Di Dedda, MC; Ghezzi, F; Serati, M; Uccella, S, 2015) |
| "We investigated the effect of a combination of vaginal ultra-low-dose estriol with lactobacilli on the sexual functioning domain of quality of life during the treatment of breast cancer survivors on an aromatase inhibitor with vaginal atrophy." | 3.81 | Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer. ( Bellen, G; Buchholz, S; Donders, G; Grob, P; Lintermans, A; Mögele, M; Neven, P; Ortmann, O; Prasauskas, V, 2015) |
| "The intensified treatment of breast cancer improves survival but has a price in terms of side-effects." | 2.48 | The management of menopausal symptoms in breast cancer survivors: case-based approach. ( de Bock, GH; Lammerink, EA; Mourits, MJ; Schröder, CP, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso, S | 2 |
| Cianci, A | 2 |
| Sarpietro, G | 1 |
| Matarazzo, MG | 1 |
| Panella, M | 1 |
| Cianci, S | 2 |
| Mueck, AO | 1 |
| Ruan, X | 1 |
| Prasauskas, V | 2 |
| Grob, P | 2 |
| Ortmann, O | 2 |
| Buchholz, S | 1 |
| Mögele, M | 1 |
| Lintermans, A | 1 |
| Bellen, G | 1 |
| Neven, P | 1 |
| Donders, G | 1 |
| Serati, M | 1 |
| Bogani, G | 1 |
| Di Dedda, MC | 1 |
| Braghiroli, A | 1 |
| Uccella, S | 1 |
| Cromi, A | 1 |
| Ghezzi, F | 1 |
| Amore, FF | 1 |
| Ventura, B | 1 |
| Bambili, E | 1 |
| Spadola, S | 1 |
| Lammerink, EA | 1 |
| de Bock, GH | 1 |
| Schröder, CP | 1 |
| Mourits, MJ | 1 |
| Cusack, L | 1 |
| Brennan, M | 1 |
| Baber, R | 1 |
| Boyle, F | 1 |
| Sharma, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects on Vaginal Health and Quality of Life in Postmenopausal Women Using Ultra Low Topic Estriol Before Vaginal Surgery for Pelvic Statics Disorders[NCT02906111] | Phase 4 | 88 participants (Anticipated) | Interventional | 2016-11-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for estriol and Sexual Dysfunction, Physiological
| Article | Year |
|---|---|
Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review.
Topics: Administration, Intravaginal; Atrophy; Combined Modality Therapy; Estriol; Female; Humans; Lactobaci | 2018 |
The management of menopausal symptoms in breast cancer survivors: case-based approach.
Topics: Acupuncture Therapy; Breast Neoplasms; Estriol; Estrogen Replacement Therapy; Female; Hot Flashes; H | 2012 |
Intra-uterine growth retardation.
Topics: Abortion, Threatened; Bone Development; Embryonic and Fetal Development; Estriol; Eye Diseases; Fema | 1968 |
2 trials available for estriol and Sexual Dysfunction, Physiological
| Article | Year |
|---|---|
Ultralow 0.03 mg vaginal estriol in postmenopausal women who underwent surgical treatment for stress urinary incontinence: effects on quality of life and sexual function.
Topics: Administration, Intravaginal; Estriol; Female; Humans; Middle Aged; Postmenopause; Postoperative Com | 2020 |
A comparison between vaginal estrogen and vaginal hyaluronic for the treatment of dyspareunia in women using hormonal contraceptive.
Topics: Adult; Atrophy; Contraceptives, Oral, Hormonal; Drug Administration Schedule; Dyspareunia; Estriol; | 2015 |
3 other studies available for estriol and Sexual Dysfunction, Physiological
| Article | Year |
|---|---|
Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Topics: Administration, Intravaginal; Aromatase Inhibitors; Atrophy; Breast Neoplasms; Combined Modality The | 2015 |
Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
Topics: Administration, Intravaginal; Atrophy; Case-Control Studies; Estriol; Female; Humans; Middle Aged; P | 2016 |
Menopausal symptoms in breast cancer survivors: management update.
Topics: Aged; Antineoplastic Agents; Anxiety; Breast Neoplasms; Clinical Trials as Topic; Depression; Estrio | 2013 |